CVS Health filed a motion seeking to disqualify top Federal Trade Commission officials from participating in a case regarding some of its businesses over alleged bias against pharmacy benefit managers.
The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through public statements show they have prejudged the matter at hand and that their participation would violate the due process rights of respondents Caremark Rx and Zinc Health Services.
CVS specified that past statements made false assertions that are critical to the merits of the case, including that pharmacy benefit managers "control" drug pricing and patient access to drugs including insulin.
Cigna Group, on behalf of Express Scripts and other of its businesses, also filed a motion seeking to disqualify Khan, Slaughter and Bedoya.
UnitedHealth Group, who reportedly filed a similar motion, didn't immediately respond to a request for comment.
The FTC in September filed an antitrust and consumer-protection lawsuit against the three largest pharmacy-benefit managers and affiliated businesses and accused the firms of inflating the price of insulin.
The FTC on Wednesday declined to comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.